Artiva Biotherapeutics, Inc. Common Stock (ARTV) stock news · $37.3M cap
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
This ARTV news page leads with what Artiva Biotherapeutics, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for ARTV yet. We will not pad this page with generic market recap.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ARTV stock page; for the tape open the quote page.
ARTV stock news FAQ
What is ARTV's latest net income?
Latest cached Artiva Biotherapeutics, Inc. Common Stock (ARTV) net income was -$83.9M. Statements: https://lician.com/financials/artv
What is ARTV's market cap?
Artiva Biotherapeutics, Inc. Common Stock (ARTV) market cap is $37.3M on the latest cached fundamentals snapshot.
What kind of company is ARTV?
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Where is ARTV stock news listed?
Cached stock news for Artiva Biotherapeutics, Inc. Common Stock (ARTV) is listed at https://lician.com/news/artv. Filings: https://lician.com/sec/artv
Not investment advice.